These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15388831)

  • 21. Total iron binding capacity or transferrin concentration alone outperforms iron and saturation indices in predicting iron deficiency.
    Hawkins RC
    Clin Chim Acta; 2007 May; 380(1-2):203-7. PubMed ID: 17376421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of parenteral iron use in a health facility and its impact in terms of hospital economics].
    Vonesch MA; Grangier G; Girard P; Dussart C
    Ann Pharm Fr; 2016 Jul; 74(4):296-303. PubMed ID: 26651954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of iron. I. intravenous iron tolerance tests in normal subjects and patients with hemochromatosis.
    GITLOW SE; BEYERS MR
    J Lab Clin Med; 1952 Mar; 39(3):337-46. PubMed ID: 14908276
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous iron and hypersensitivity.
    Prescrire Int; 2007 Apr; 16(88):71-2. PubMed ID: 17465035
    [No Abstract]   [Full Text] [Related]  

  • 25. Study of carbonyl iron/poly(butylcyanoacrylate) (core/shell) particles as anticancer drug delivery systems Loading and release properties.
    Arias JL; Linares-Molinero F; Gallardo V; Delgado AV
    Eur J Pharm Sci; 2008 Mar; 33(3):252-61. PubMed ID: 18249100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbon monoxide as an intrinsic ligand to iron in the active site of the iron-sulfur-cluster-free hydrogenase H2-forming methylenetetrahydromethanopterin dehydrogenase as revealed by infrared spectroscopy.
    Lyon EJ; Shima S; Boecher R; Thauer RK; Grevels FW; Bill E; Roseboom W; Albracht SP
    J Am Chem Soc; 2004 Nov; 126(43):14239-48. PubMed ID: 15506791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration.
    Chowers I; Wong R; Dentchev T; Farkas RH; Iacovelli J; Gunatilaka TL; Medeiros NE; Presley JB; Campochiaro PA; Curcio CA; Dunaief JL; Zack DJ
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2135-40. PubMed ID: 16639025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theoretical spectroscopy of model-nonheme [Fe(IV)OL5]2+ complexes in their lowest triplet and quintet states using multireference ab initio and density functional theory methods.
    Neese F
    J Inorg Biochem; 2006 Apr; 100(4):716-26. PubMed ID: 16504299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. More than a decade of experience and still no consensus: controversies in iron therapy.
    Besarab A
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S1-3. PubMed ID: 17699371
    [No Abstract]   [Full Text] [Related]  

  • 30. [Iron, calcium and magnesium salts].
    Ude C; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2009; 38(3):224-31. PubMed ID: 19396915
    [No Abstract]   [Full Text] [Related]  

  • 31. Dioxygen activation at non-heme iron: insights from rapid kinetic studies.
    Korendovych IV; Kryatov SV; Rybak-Akimova EV
    Acc Chem Res; 2007 Jul; 40(7):510-21. PubMed ID: 17521158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Stability of parenteral formulations of apomorphine].
    Pandolfo V; Tanini R; Polidori G; Santoni G
    Boll Chim Farm; 1984 Sep; 123(9):449-52. PubMed ID: 6529497
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood iron in leukemias].
    SCHULZ FH; MORCZEK A
    Z Gesamte Inn Med; 1951 Oct; 6(19-20):611-6. PubMed ID: 14901940
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of iron in liver disease].
    KIPPING H; SCHMOLDT H
    Dtsch Arch Klin Med; 1951; 198(4):434-9. PubMed ID: 14906101
    [No Abstract]   [Full Text] [Related]  

  • 35. Redox reactions in the Fe-As-O2 system.
    Johnston RB; Singer PC
    Chemosphere; 2007 Sep; 69(4):517-25. PubMed ID: 17521697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Iron metabolism in acute hepatitis. II].
    BENDA L; RISSEL E; SCHOLDA G
    Wien Klin Wochenschr; 1951 Oct; 63(42):794-5. PubMed ID: 14901767
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of transferrin in atherosclerosis.
    Kibel A; Belovari T; Drenjancević-Perić I
    Med Hypotheses; 2008; 70(4):793-7. PubMed ID: 17959319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferrin receptor 2 mediates uptake of transferrin-bound and non-transferrin-bound iron.
    Graham RM; Reutens GM; Herbison CE; Delima RD; Chua AC; Olynyk JK; Trinder D
    J Hepatol; 2008 Feb; 48(2):327-34. PubMed ID: 18083267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updating practices in an evolving IV iron and anemia environment: practical solutions.
    Amerling R; Easom A; Juergensen P
    Nephrol Nurs J; 2007; 34(5):533-41; quiz 542-3. PubMed ID: 18041456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Iron metabolism and deficiency in regenerate pernicious anemia].
    GOLDECK H; REMY D
    Dtsch Arch Klin Med; 1951; 198(4):422-33. PubMed ID: 14906100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.